IL124004A - Stable pharmaceutical composition comprising ngf - Google Patents

Stable pharmaceutical composition comprising ngf

Info

Publication number: IL124004A
Authority: IL; Israel
Prior art keywords: ngf; pharmaceutical composition; stable pharmaceutical; maturation; survival
Prior art date: 1995-11-07

Application number

IL12400496A

Other languages

English (en)

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-07

Filing date

1996-10-21

Publication date

2003-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24214304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL124004(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-10-21 Application filed by Genentech Inc filed Critical Genentech Inc

2003-10-31 Publication of IL124004A publication Critical patent/IL124004A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pretreatment Of Seeds And Plants (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

IL12400496A 1995-11-07 1996-10-21 Stable pharmaceutical composition comprising ngf IL124004A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US55468595A	1995-11-07	1995-11-07

Publications (1)

Publication Number	Publication Date
IL124004A true IL124004A (en)	2003-10-31

Family

ID=24214304

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12400496A IL124004A (en)	1995-11-07	1996-10-21	Stable pharmaceutical composition comprising ngf

Country Status (17)

Country	Link
EP (1)	EP0862452B1 (xx)
JP (1)	JP4057058B2 (xx)
KR (1)	KR100497087B1 (xx)
CN (1)	CN1126567C (xx)
AT (1)	ATE255903T1 (xx)
AU (1)	AU721112B2 (xx)
BR (1)	BR9611571B1 (xx)
CA (1)	CA2234231C (xx)
DE (1)	DE69631063T2 (xx)
DK (1)	DK0862452T3 (xx)
ES (1)	ES2211991T3 (xx)
IL (1)	IL124004A (xx)
MX (1)	MX9803342A (xx)
PT (1)	PT862452E (xx)
TR (1)	TR199800811T2 (xx)
WO (1)	WO1997017087A1 (xx)
ZA (1)	ZA969290B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7214998A (en) *	1997-04-11	1998-11-11	Regents Of The University Of California, The	Ngf for the prevention of demyelination in the nervous system
US6171586B1 (en)	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US6663899B2 (en)	1997-06-13	2003-12-16	Genentech, Inc.	Controlled release microencapsulated NGF formulation
US6991790B1 (en)	1997-06-13	2006-01-31	Genentech, Inc.	Antibody formulation
US6113947A (en) *	1997-06-13	2000-09-05	Genentech, Inc.	Controlled release microencapsulated NGF formulation
US7282482B2 (en)	1998-04-08	2007-10-16	The Regents Of The University Of California	NGF for the prevention of demyelination in the nervous system
US20030166525A1 (en)	1998-07-23	2003-09-04	Hoffmann James Arthur	FSH Formulation
JP4719357B2 (ja) *	1998-07-23	2011-07-06	アレストレイディングソシエテアノニム	Ｆｓｈ及びｆｓｈ変異体の製剤、製品及び方法
CA2452114C (en) *	2001-06-26	2010-11-16	Takeda Chemical Industries, Ltd.	Tgf-.beta. superfamily production/secretion promoter
DE10219545A1 (de) *	2002-04-26	2003-11-06	Lang Florian	Regulation der Apoptose
CA2518903C (en)	2003-04-02	2013-02-05	Ares Trading S.A.	Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
AR044302A1 (es) *	2003-05-13	2005-09-07	Ares Trading Sa	Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
CN1318087C (zh) *	2003-06-06	2007-05-30	北京三诺佳邑生物技术有限责任公司	去白蛋白神经生长因子制剂
ES2414705T3 (es)	2003-06-20	2013-07-22	Ares Trading S.A.	Formulaciones liofilizadas de FSH/LH
DE10333317A1 (de) *	2003-07-22	2005-02-17	Biotecon Therapeutics Gmbh	Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
CN108348579B (zh) *	2015-04-21	2021-04-27	舒泰神（北京）生物制药股份有限公司	神经生长因子组合物及注射粉剂
CN107846850A (zh) *	2016-01-04	2018-03-27	葡萄王生技股份有限公司	预防听力退化的活性物质、含其的组合物、及其制备方法
CN114252519B (zh) *	2020-09-23	2023-11-24	舒泰神（北京）生物制药股份有限公司	一种测定神经生长因子纯度的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL109350A (en) *	1993-05-12	2001-01-28	Genentech Inc	Stable liquid compositions of gamma interferon
US6277828B1 (en) *	1993-08-20	2001-08-21	Syntex (U.S.A.) Inc.	Pharmaceutical formulations of nerve growth factor

1996
- 1996-10-21 DE DE69631063T patent/DE69631063T2/de not_active Expired - Lifetime
- 1996-10-21 IL IL12400496A patent/IL124004A/xx not_active IP Right Cessation
- 1996-10-21 CA CA002234231A patent/CA2234231C/en not_active Expired - Lifetime
- 1996-10-21 BR BRPI9611571-8A patent/BR9611571B1/pt not_active IP Right Cessation
- 1996-10-21 KR KR10-1998-0703357A patent/KR100497087B1/ko not_active Expired - Lifetime
- 1996-10-21 ES ES96937710T patent/ES2211991T3/es not_active Expired - Lifetime
- 1996-10-21 WO PCT/US1996/016881 patent/WO1997017087A1/en not_active Ceased
- 1996-10-21 DK DK96937710T patent/DK0862452T3/da active
- 1996-10-21 PT PT96937710T patent/PT862452E/pt unknown
- 1996-10-21 TR TR1998/00811T patent/TR199800811T2/xx unknown
- 1996-10-21 CN CN96198066A patent/CN1126567C/zh not_active Expired - Lifetime
- 1996-10-21 AU AU75186/96A patent/AU721112B2/en not_active Expired
- 1996-10-21 EP EP96937710A patent/EP0862452B1/en not_active Expired - Lifetime
- 1996-10-21 JP JP51819197A patent/JP4057058B2/ja not_active Expired - Lifetime
- 1996-10-21 AT AT96937710T patent/ATE255903T1/de active
- 1996-11-05 ZA ZA9609290A patent/ZA969290B/xx unknown
1998
- 1998-04-28 MX MX9803342A patent/MX9803342A/es active IP Right Grant

Also Published As

Publication number	Publication date
BR9611571B1 (pt)	2009-01-13
BR9611571A (pt)	1999-03-30
CA2234231C (en)	2009-04-14
EP0862452A1 (en)	1998-09-09
CA2234231A1 (en)	1997-05-15
KR100497087B1 (ko)	2005-09-09
CN1201394A (zh)	1998-12-09
DE69631063T2 (de)	2004-09-30
AU721112B2 (en)	2000-06-22
EP0862452B1 (en)	2003-12-10
KR19990067350A (ko)	1999-08-16
MX9803342A (es)	1998-09-30
TR199800811T2 (xx)	1998-07-21
HK1015261A1 (en)	1999-10-15
ATE255903T1 (de)	2003-12-15
ZA969290B (en)	1998-05-05
CN1126567C (zh)	2003-11-05
JP2002502358A (ja)	2002-01-22
WO1997017087A1 (en)	1997-05-15
JP4057058B2 (ja)	2008-03-05
ES2211991T3 (es)	2004-07-16
DK0862452T3 (da)	2004-04-05
DE69631063D1 (de)	2004-01-22
PT862452E (pt)	2004-04-30
AU7518696A (en)	1997-05-29

Similar Documents

Publication	Publication Date	Title
IL124004A (en)	2003-10-31	Stable pharmaceutical composition comprising ngf
HU9600371D0 (en)	1996-04-29	Pharmaceutical formulations of nerve growth factor
PL319833A1 (en)	1997-09-01	Compounds and composition for carrying active media
AU4718496A (en)	1996-09-11	Use of aerogels in agriculture
IL111734A0 (en)	1995-01-24	Compositions for the preparation of in vivo therapeutic products
AU693747B2 (en)	1998-07-02	Imidazo(4,5-c)pyridin-4-amines
HUT78058A (hu)	1999-07-28	A keratinocita növekedési faktor analógjai
IE863279L (en)	1987-06-17	Plasminogen activator composition
NZ333724A (en)	2000-10-27	Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ZA933598B (en)	1993-12-13	New pharmaceutical used of krill enyzmes
MY115211A (en)	2003-04-30	Novel amino acid derivatives, their preparation and use
UA35611C2 (uk)	2001-04-16	Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
AU1031697A (en)	1997-06-11	Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
AU8332791A (en)	1992-03-02	Oral pharmaceutical compositions containing melatonin
GB9616896D0 (en)	1996-09-25	Pharmaceutical compositions
PL318130A1 (en)	1997-05-12	Terpenod derivatives (of sarcodictyine)as antineoplastic agents
GR3029319T3 (en)	1999-05-28	Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
MD970269A (en)	1999-05-31	Clavulanates
TW374085B (en)	1999-11-11	Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE3560313D1 (en)	1987-08-13	Improvements in or relating to anticonvulsant agents
AU4299696A (en)	1996-06-17	Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
AU7533394A (en)	1995-02-28	Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
MD232C2 (ro)	1995-11-30	Mediu pentru cultivarea microorganismelor Campylobacter jejuni/coli
NZ236734A (en)	1993-02-25	Alisamycin, pharmaceutical compositions and actinomycete culture (dsm 5559)
UA5743C2 (uk)	1994-12-29	Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання

Legal Events

Date	Code	Title
2004-03-28	FF	Patent granted
2004-05-12	KB	Patent renewed
2006-12-07	KB	Patent renewed
2014-10-30	KB	Patent renewed
2017-05-29	EXP	Patent expired